Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Diagnostic Approach and Treatment of Aspergillus Infection

Diagnostic Tests

  • The Infectious Diseases Society of America recommends serum galactomannan testing and PCR from the site of infection as diagnostic tests for suspected Aspergillus infection, especially in immunocompromised patients 1, 2
  • Blood or serum Aspergillus PCR testing is strongly recommended for patients with severe immunocompromise, such as those with hematological malignancy or transplant recipients 5
  • The European Respiratory Society notes that BAL galactomannan has higher sensitivity (85-91%) compared to serum galactomannan for diagnosis of chronic pulmonary aspergillosis 8, 9
  • Aspergillus IgG antibody testing is a key diagnostic feature for chronic pulmonary aspergillosis with high sensitivity (>90%) 8, 10

Treatment

  • The Infectious Diseases Society of America recommends voriconazole as the preferred first-line agent for treatment of invasive aspergillosis 1, 2
  • Liposomal amphotericin B is recommended as an alternative first-line agent if voriconazole cannot be tolerated or is contraindicated 2
  • The Infectious Diseases Society of America suggests that treatment should be continued for a minimum of 6-12 weeks, depending on the degree and duration of immunosuppression 11

Monitoring and Follow-up

  • The Infectious Diseases Society of America recommends follow-up chest CT scan to assess response to treatment after a minimum of 2 weeks of therapy 2
  • Therapeutic drug monitoring is strongly recommended for patients receiving triazole-based therapy to enhance efficacy and minimize toxicity 2, 11